Skip to content
On this page:OverviewPublicationsResearchersInstitutionsOpen access
PICO Portalanswers from OpenAlex

Direktoratet for medisinske produkter

InstitutionResearch output, impact & collaborations

Direktoratet for medisinske produkter is a institution indexed in PICO Portal from OpenAlex.

What is known about Direktoratet for medisinske produkter?

PICO Portalrecord summary

Direktoratet for medisinske produkter is a research organisation in Oslo, NO. OpenAlex records 550 works and 15,955 citations for it. 158 researchers list it as their most recent affiliation.

How many works does Direktoratet for medisinske produkter have?

PICO Portalindexed works

Direktoratet for medisinske produkter has 550 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Direktoratet for medisinske produkter have?

PICO Portalcitation count

Direktoratet for medisinske produkter has 15,955 citations in the OpenAlex counts PICO Portal stores.

How many researchers are at Direktoratet for medisinske produkter?

PICO Portalresearcher count

Direktoratet for medisinske produkter has 158 researchers in the PICO Portal index.

What is the average h-index at Direktoratet for medisinske produkter?

PICO Portalavg h-index

Direktoratet for medisinske produkter has an average h-index of 17 in OpenAlex.

What is the ROR of Direktoratet for medisinske produkter?

PICO Portalror

The ROR for Direktoratet for medisinske produkter is on the source record.

What is the OpenAlex record for Direktoratet for medisinske produkter?

PICO Portalopenalex

The OpenAlex for Direktoratet for medisinske produkter is on the source record.

Who are the most-cited researchers behind Direktoratet for medisinske produkter?

PICO Portaltop researchers by citations
1
Anja Schiel · Health Systems, Economic Evaluations, Quality of Life
45 works1,062 citations

What are the most-cited papers on Direktoratet for medisinske produkter?

PICO Portalmost cited works
Induction of Thyroid Hormone-Degrading Deiodinase in Cardiac Hypertrophy and Failure
Frank W. J. S. Wassen, Anja Schiel, George G. J. M. Kuiper, Ellen Kaptein, Onno Bakker, Theo J. Visser, Warner S. Simonides
Endocrinology. 2002138 CitationsOPEN ACCESS
Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure
Henk P.J. Buermans, Everaldo M. Redout, Anja Schiel, René J.P. Musters, Marian J. Zuidwijk, Paul P. Eijk, Cornelis van Hardeveld, Soemini Kasanmoentalib, Frans C. Visser, Bauke Ylstra, Warner S. Simonides
Physiological Genomics. 2005136 CitationsOPEN ACCESS
Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform Trials
Olivier Collignon, Christian Gärtner, Anna‐Bettina Haidich, Robert Hemmings, Benjamin Hofner, Frank Pétavy, Martin Posch, Khadija Rantell, Kit C. B. Roes, Anja Schiel
Clinical Pharmacology & Therapeutics. 202091 Citations
The use of external controls: To what extent can it currently be recommended?
Hans Ulrich Burger, Christoph Gerlinger, Chris Harbron, Armin Koch, Martin Posch, Justine Rochon, Anja Schiel
Pharmaceutical Statistics. 202188 CitationsOPEN ACCESS
Intrauterine Exposure to Maternal Atherosclerotic Risk Factors Increases the Susceptibility to Atherosclerosis in Adult Life
Fanneke E. Alkemade, Adriana C. Gittenberger–de Groot, Anja Schiel, J. Conny VanMunsteren, Bianca Hogers, Leontien S. J. van Vliet, Robert E. Poelmann, Louis M. Havekes, Ko Willems van Dijk, Marco C. DeRuiter
Arteriosclerosis Thrombosis and Vascular Biology. 200772 CitationsOPEN ACCESS

How much of the research on Direktoratet for medisinske produkter is open access?

PICO Portalopen access share
73%OPEN ACCESS
Gold
0%
Green
27%
Hybrid
9%
Bronze
36%
Closed
27%

Related on PICO Portal

470M+ articles · 14-day free trial